1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENERATION BIO CO

Generation Bio Co

XNAS: GBIO

Download real time

0.56 0.03 (5.66%)

New 52W Low in past week

325.8K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
4S
9W
0O
3T
37.4

Market Cap

Below industry Median
-0.3

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
0.4

Price to Book

Below industry Median
0.0

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Generation Bio Co is on 20 Mar 2025 for the purpose of Generation Bio Co Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Generation Bio Co

The latest disclosure was made by Kevin Conway in Generation Bio Co where a trade of 587 Common Stock done was reported to US exchanges on Jan. 15, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 587 17,649 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 5,274 42,185 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 5,274 1,347,766 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 1,828 1,345,938 - 0.9 1,623 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 1,160 16,373 - 0.9 1,030 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 3,347 17,533 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 3,347 30,121 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,592 22,510 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,592 12,732 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 552 21,958 - 0.9 490 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,147 9,170 - - Restricted Stock Units
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 398 127,709 - 0.9 353 Common Stock
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 1,147 128,107 - - Common Stock
Kevin Conway Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2025 587 4,694 - - Restricted Stock Units
Kevin Conway Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. 15 Jan 2025 204 17,445 - 0.9 181 Common Stock
Kevin Conway Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 355,260 355,260 - - Stock Option (right to buy)
Anthony G. Quinn Director Purchase of securities on an exchange or from another person at price $ 0.96 per share. 10 Jan 2025 125,791 214,286 - 1.0 120,759 Common Stock
Anthony G. Quinn Director Purchase of securities on an exchange or from another person at price $ 0.97 per share. 10 Jan 2025 85,000 299,286 - 1.0 82,450 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 901,690 901,690 - - Stock Option (right to buy)
Yalonda Howze CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 251,030 251,030 - - Stock Option (Right to Buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 251,030 251,030 - - Stock Option (right to buy)
Phillip Samayoa CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 251,030 251,030 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,673 57,840 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,147 122,434 - - Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 1,548 1,337,629 - 2.4 3,746 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 492 56,167 - 2.4 1,191 Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,147 10,317 - - Restricted Stock Units
Paone Antionette CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 468 16,055 - 2.4 1,133 Common Stock
Howze Yalonda CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. 15 Oct 2024 3,347 15,169 - 2.4 8,100 Common Stock
Stanton Matthew CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 492 247,319 - 2.4 1,191 Common Stock
Stanton Matthew CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 247,811 - - Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 56,659 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 5,274 1,339,177 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 492 57,348 - 2.4 1,191 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,592 14,324 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.42 per share. 15 Oct 2024 337 122,097 - 2.4 816 Common Stock
Paone Antionette CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,592 16,523 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 Oct 2024 983 14,186 - - Common Stock
Howze Yalonda CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 3,347 33,468 - - Restricted Stock Units
Stanton Matthew CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 15,059 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,673 1,673 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 5,274 47,459 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2024 1,674 15,059 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 5,274 1,335,451 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 5,274 52,733 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 1,548 1,333,903 - 2.9 4,536 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 246,629 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 492 246,137 - 2.9 1,442 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 16,733 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 492 53,804 - 2.9 1,442 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 54,296 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,674 16,733 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 492 54,985 - 2.9 1,442 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,673 55,477 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,673 3,346 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 983 11,822 - 2.9 2,880 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 3,347 12,805 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 3,347 36,815 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,592 15,916 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,592 15,399 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 468 14,931 - 2.9 1,371 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. 15 Jul 2024 337 121,287 - 2.9 987 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,147 11,464 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2024 1,147 121,624 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 2.74 per share. 01 Jul 2024 6,719 13,807 - 2.7 18,410 Common Stock
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2024 60,000 60,000 - - Stock Option (right to buy)
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 5,274 1,325,006 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 5,274 58,007 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 1,548 1,323,458 - 3.7 5,728 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 18,407 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 245,447 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 492 244,955 - 3.7 1,820 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,673 53,114 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 492 52,622 - 3.7 1,820 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 18,407 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,673 5,019 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,674 51,933 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 492 51,441 - 3.7 1,820 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 13,388 13,388 - - Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 13,388 40,162 - - Restricted Stock Units
Yalonda Howze CHIEF LEGAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 3,930 9,458 - 3.7 14,541 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,592 17,508 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,592 14,275 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 468 13,807 - 3.7 1,732 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,147 114,095 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 15 Apr 2024 337 113,758 - 3.7 1,247 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2024 1,147 12,611 - - Restricted Stock Units
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 0 - - Restricted Stock Units
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. 29 Jan 2024 1,476 49,164 - 1.9 2,804 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.90 per share. 29 Jan 2024 1,476 385,628 - 1.9 2,804 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 387,104 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 0 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2024 5,021 50,640 - - Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 21,094 63,281 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 246,093 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 1,674 50,840 - - Common Stock
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 380,286 - - Common Stock
Kerr Douglas CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 382,083 - 1.9 4,431 Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 45,619 - 1.9 4,431 Common Stock
Paone Antionette CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 1,430 8,523 - 1.9 2,731 Common Stock
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 7,437 - - Restricted Stock Units
Norkunas Matthew CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 49,166 - 1.9 4,431 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 21,094 1,327,042 - - Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 111,381 - - Common Stock
Stanton Matthew CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 239,399 - 1.9 4,922 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 8,121 1,305,948 - 1.9 15,511 Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 1,590 112,948 - 1.9 3,037 Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Kerr Douglas CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Kerr Douglas CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 377,709 - 1.9 4,922 Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 47,939 - - Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 23,437 1,314,069 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,367 19,100 - - Restricted Stock Units
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 1,674 6,692 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 1,430 109,951 - 1.9 2,731 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 9,953 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,367 14,890 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 41,245 - 1.9 4,922 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 0 - - Restricted Stock Units
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 51,486 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 241,976 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 43,822 - - Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 0 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 23,437 0 - - Restricted Stock Units
Samayoa Phillip CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,587 13,758 - - Restricted Stock Units
Stanton Matthew CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,320 243,773 - 1.9 4,431 Common Stock
Norkunas Matthew CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,577 44,792 - 1.9 4,922 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 47,369 - - Common Stock
Zimmermann Tracy CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 7,437 0 - - Restricted Stock Units
Stanton Matthew CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 20,081 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 2,207 12,683 - 1.9 4,215 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 7,310 1,319,732 - 1.9 13,962 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,587 114,538 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. 15 Jan 2024 581 50,259 - 1.9 1,110 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 6,694 384,403 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 0 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2024 4,125 0 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Paone Antionette CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 1.62 per share. 02 Jan 2024 2,445 5,828 - 1.6 3,961 Common Stock
Samayoa Phillip CHIEF STRATEGY OFFICER Sale of securities on an exchange or to another person at price $ 1.62 per share. 02 Jan 2024 2,445 107,256 - 1.6 3,961 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 506,250 506,250 - - Stock Option (right to buy)
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Howze Yalonda CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 118,837 118,837 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 160,650 160,650 - - Stock Option (right to buy)
Appelhans Dannielle Director Purchase of securities on an exchange or from another person at price $ 1.79 per share. 08 Dec 2023 7,363 7,363 - 1.8 13,180 Common Stock
Appelhans Dannielle Director Purchase of securities on an exchange or from another person at price $ 1.82 per share. 08 Dec 2023 637 12,637 - 1.8 1,159 Common Stock
Appelhans Dannielle Director Purchase of securities on an exchange or from another person at price $ 1.50 per share. 04 Dec 2023 12,000 12,000 - 1.5 18,000 Common Stock
G. Anthony Quinn Director Purchase of securities on an exchange or from another person at price $ 1.41 per share. 01 Dec 2023 88,495 88,495 - 1.4 124,778 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Howze Yalonda CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Norkunas Matthew CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Stanton Matthew CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Rowland Charles A. Director Purchase of securities on an exchange or from another person at price $ 1.31 per share. 01 Dec 2023 192,960 384,757 - 1.3 252,778 Common Stock
W. Donald Nicholson Director Purchase of securities on an exchange or from another person at price $ 1.44 per share. 01 Dec 2023 100,000 213,576 - 1.4 144,000 Common Stock
McDonough Geoffrey Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 240,470 240,470 - - Stock Option (right to buy)
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 1.50 per share. 01 Dec 2023 150,000 534,757 - 1.5 225,000 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 76,310 76,310 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 4.93 per share. 23 Aug 2023 3,116 2,914 - 4.9 15,362 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 367,333 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 365,150 - 5.1 11,090 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 23,437 46,874 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 23,437 1,282,621 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 7,476 1,275,145 - 5.1 37,978 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 231,468 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 229,285 - 5.1 11,090 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 31,131 - 5.1 11,090 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 3,348 10,040 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 983 33,496 - 5.1 4,994 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 3,348 34,479 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 33,314 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 2,183 31,131 - 5.1 11,090 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 14,874 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 7,437 33,314 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 7,241 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 1,211 6,030 - 5.1 6,152 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 8,250 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 8,250 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.08 per share. 15 Jul 2023 1,211 104,342 - 5.1 6,152 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2023 4,125 105,553 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Sale of securities on an exchange or to another person at price $ 5.29 per share. 03 Jul 2023 3,116 101,428 - 5.3 16,484 Common Stock
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 25,000 25,000 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 4.61 per share. 25 Apr 2023 2,914 0 - 4.6 13,434 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 356,780 - 4.5 9,824 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 358,963 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 6,879 1,256,068 - 4.5 30,956 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 23,437 1,262,947 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 23,437 70,311 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 224,031 - 4.5 9,824 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 226,214 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 28,060 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 25,877 - 4.5 9,824 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 22,311 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 7,437 28,060 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 2,183 25,877 - 4.5 9,824 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 12,375 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 4,125 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 1,211 2,914 - 4.5 5,450 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 102,639 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Apr 2023 4,125 12,375 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. 15 Apr 2023 1,211 101,428 - 4.5 5,450 Common Stock
Yalonda Howze CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 107,100 107,100 - - Stock Option (Right to Buy)
Yalonda Howze CHIEF LEGAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2023 53,550 53,550 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.56 per share. 26 Jan 2023 2,695 0 - 5.6 14,984 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 84,375 84,375 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 168,750 168,750 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 13,388 13,388 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 26,775 26,775 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 53,550 53,550 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 50,935 50,935 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 25,467 25,467 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 36,691 36,691 - - Stock Option (right to buy)
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2023 18,345 18,345 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 354,104 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 351,526 - 5.1 13,148 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 23,438 93,748 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 23,438 1,247,632 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 8,122 1,239,510 - 5.1 41,422 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 218,777 - 5.1 13,148 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 221,355 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 23,201 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 20,623 - 5.1 13,148 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 23,201 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 7,438 29,748 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 2,578 20,623 - 5.1 13,148 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 1,430 2,695 - 5.1 7,293 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 16,500 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 4,125 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 99,944 - - Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2023 4,125 16,500 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. 15 Jan 2023 1,430 98,514 - 5.1 7,293 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 4.57 per share. 10 Jan 2023 1,865 0 - 4.6 8,523 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Sale of securities on an exchange or to another person at price $ 5.11 per share. 09 Jan 2023 1,865 95,819 - 5.1 9,530 Common Stock
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 5.12 per share. 05 Jan 2023 9,500 9,500 - 5.1 48,640 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.03 per share. 27 Oct 2022 2,914 0 - 5.0 14,657 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 344,801 - 5.6 12,252 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 346,985 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 23,438 117,186 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 23,438 1,232,724 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 10,395 1,222,329 - 5.6 58,316 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 216,101 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 213,917 - 5.6 12,252 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 17,947 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 15,763 - 5.6 12,252 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 2,184 15,763 - 5.6 12,252 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 17,947 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 7,438 37,186 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 4,125 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 20,625 - - Restricted Stock Units
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 1,211 2,914 - 5.6 6,794 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. 15 Oct 2022 1,211 95,819 - 5.6 6,794 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 20,625 - - Restricted Stock Units
Phillip Samayoa CHIEF STRATEGY OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2022 4,125 97,030 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.24 per share. 29 Sep 2022 2,828 0 - 5.2 14,819 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.26 per share. 19 Sep 2022 15,750 191,797 - 5.3 82,845 Common Stock
Phillip Samayoa CHIEF STRATEGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Sep 2022 110,000 110,000 - - Stock Option (right to buy)
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.41 per share. 15 Sep 2022 17,147 142,566 - 5.4 92,765 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.48 per share. 15 Sep 2022 33,481 176,047 - 5.5 183,476 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 5.32 per share. 15 Sep 2022 4,610 2,828 - 5.3 24,525 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.20 per share. 13 Sep 2022 18,784 119,819 - 5.2 97,752 Common Stock
Charles A. Rowland Director Purchase of securities on an exchange or from another person at price $ 5.30 per share. 13 Sep 2022 5,600 125,419 - 5.3 29,652 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 343,914 - - Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 339,547 - 7.2 31,355 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 14,150 1,209,286 - 7.2 101,597 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 46,876 1,223,436 - - Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 46,876 140,624 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 213,030 - - Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 208,663 - 7.2 31,355 Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 14,876 - - Common Stock
Matthew Norkunas CHIEF FINANCIAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Matthew Norkunas CHIEF FINANCIAL OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 10,509 - 7.2 31,355 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 44,624 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 14,876 14,876 - - Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 4,367 10,509 - 7.2 31,355 Common Stock
Dannielle Appelhans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 38,400 38,400 - - Stock Option (right to buy)
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 8,250 9,860 - - Common Stock
Antionette Paone CHIEF OPERATING OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 15 Jul 2022 2,422 7,438 - 7.2 17,390 Common Stock
Antionette Paone CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jul 2022 8,250 24,750 - - Restricted Stock Units
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2022 19,200 19,200 - - Stock Option (right to buy)
Donald W. Nicholson Director Purchase of securities on an exchange or from another person at price $ 4.71 per share. 09 Mar 2022 8,126 113,576 - 4.7 38,273 Common Stock
Donald W. Nicholson Director Purchase of securities on an exchange or from another person at price $ 4.79 per share. 09 Mar 2022 2,293 105,450 - 4.8 10,983 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 59,500 59,500 - - Restricted Stock Units
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 119,000 119,000 - - Stock Option (right to buy)
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 187,500 187,500 - - Restricted Stock Units
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 375,000 375,000 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 59,500 59,500 - - Restricted Stock Units
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 119,000 119,000 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 119,000 119,000 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 59,500 59,500 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 59,500 59,500 - - Restricted Stock Units
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jan 2022 119,000 119,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Gift of securities by or to the insider at price $ 0.00 per share. 28 Oct 2021 72,837 0 - 0 Common Stock
Anthony G. Quinn Director Gift of securities by or to the insider at price $ 0.00 per share. 28 Oct 2021 72,837 72,837 - 0 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 24.60 per share. 27 Sep 2021 30 608 - 24.6 738 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 24.59 per share. 27 Sep 2021 16,556 0 - 24.6 407,112 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.25 per share. 27 Sep 2021 24 638 - 25.3 606 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.24 per share. 27 Sep 2021 13,089 16,556 - 25.2 330,366 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.70 per share. 27 Sep 2021 51,294 29,645 - 25.7 1,318,256 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.71 per share. 27 Sep 2021 95 662 - 25.7 2,442 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 28.07 per share. 14 Sep 2021 4,500 198,154 - 28.1 126,315 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Sep 2021 4,500 85,577 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 14 Sep 2021 4,500 202,654 - 4.6 20,655 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 25.69 per share. 10 Sep 2021 2,200 198,954 - 25.7 56,518 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2021 3,000 90,077 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 26.74 per share. 10 Sep 2021 800 198,154 - 26.7 21,392 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 10 Sep 2021 3,000 201,154 - 4.6 13,770 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 25.04 per share. 23 Aug 2021 1,500 198,154 - 25.0 37,560 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Aug 2021 1,500 93,077 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 23 Aug 2021 1,500 199,654 - 4.6 6,885 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 22.18 per share. 10 Aug 2021 1,000 198,654 - 22.2 22,180 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2021 1,500 94,577 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 24.19 per share. 10 Aug 2021 100 198,154 - 24.2 2,419 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 23.36 per share. 10 Aug 2021 400 198,254 - 23.4 9,344 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 10 Aug 2021 1,500 199,654 - 4.6 6,885 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 24.40 per share. 12 Jul 2021 1,300 199,854 - 24.4 31,720 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Jul 2021 3,000 96,077 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 25.51 per share. 12 Jul 2021 1,700 198,154 - 25.5 43,367 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 12 Jul 2021 3,000 201,154 - 4.6 13,770 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 24.99 per share. 08 Jul 2021 1,629 328,447 - 25.0 40,709 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jul 2021 3,518 38,699 - - Stock Option (right to buy)
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 25.39 per share. 08 Jul 2021 1,889 326,558 - 25.4 47,962 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. 08 Jul 2021 3,518 330,076 - 5.2 18,153 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 26.39 per share. 24 Jun 2021 4,092 0 - 26.4 107,988 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 26.38 per share. 24 Jun 2021 8 608 - 26.4 211 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.78 per share. 24 Jun 2021 50 616 - 25.8 1,289 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.77 per share. 24 Jun 2021 26,858 4,092 - 25.8 692,131 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.08 per share. 21 Jun 2021 34,162 59,281 - 25.1 856,783 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.70 per share. 21 Jun 2021 53 666 - 25.7 1,362 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.08 per share. 21 Jun 2021 63 719 - 25.1 1,580 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.69 per share. 21 Jun 2021 28,331 30,950 - 25.7 727,823 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.19 per share. 21 Jun 2021 47 782 - 25.2 1,184 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 24.75 per share. 21 Jun 2021 61 829 - 24.8 1,510 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.20 per share. 21 Jun 2021 25,208 93,443 - 25.2 635,242 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 24.76 per share. 21 Jun 2021 33,261 118,651 - 24.8 823,542 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.14 per share. 21 Jun 2021 7 890 - 25.1 176 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 24.82 per share. 21 Jun 2021 111 897 - 24.8 2,755 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.12 per share. 21 Jun 2021 3,796 151,912 - 25.1 95,356 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 24.82 per share. 21 Jun 2021 59,978 155,708 - 24.8 1,488,654 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 15 Jun 2021 1,500 199,654 - 4.6 6,885 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 1,500 99,077 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 28.08 per share. 15 Jun 2021 1,500 198,154 - 28.1 42,120 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 10 Jun 2021 6,000 204,154 - 4.6 27,540 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jun 2021 6,000 100,577 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 27.23 per share. 10 Jun 2021 6,000 198,154 - 27.2 163,380 Common Stock
Charles A. Rowland Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Gustav A. Christensen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Anthony G. Quinn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Jason P. Rhodes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Catherine Stehman-Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Donald W. Nicholson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2021 15,000 15,000 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 34.05 per share. 27 May 2021 1,500 198,154 - 34.1 51,075 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 May 2021 1,500 106,577 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 27 May 2021 1,500 199,654 - 4.6 6,885 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 10 May 2021 8,600 206,754 - 0.6 5,160 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2021 228 108,077 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2021 172 16,422 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2021 8,600 16,594 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 31.05 per share. 10 May 2021 400 198,154 - 31.1 12,420 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 10 May 2021 228 198,554 - 4.6 1,047 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 10 May 2021 172 198,326 - 0.6 103 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 32.19 per share. 10 May 2021 300 198,154 - 32.2 9,657 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 31.03 per share. 10 May 2021 2,100 198,454 - 31.0 65,163 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 30.37 per share. 10 May 2021 6,200 200,554 - 30.4 188,294 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 36.32 per share. 03 May 2021 1,924 1,174,080 - 36.3 69,880 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 35.47 per share. 03 May 2021 8,076 1,176,004 - 35.5 286,456 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 36.30 per share. 03 May 2021 510 0 - 36.3 18,513 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 03 May 2021 2,500 2,500 - 4.6 11,475 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 May 2021 2,500 86,407 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 35.54 per share. 03 May 2021 1,990 510 - 35.5 70,725 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 35.10 per share. 23 Apr 2021 10,000 1,184,080 - 35.1 351,000 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 33.32 per share. 22 Apr 2021 2,500 0 - 33.3 83,300 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 22 Apr 2021 2,500 2,500 - 4.6 11,475 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2021 2,500 88,907 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 21 Apr 2021 1,500 199,654 - 0.6 900 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 34.03 per share. 21 Apr 2021 1,500 198,154 - 34.0 51,045 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2021 1,500 26,694 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2021 1,500 25,194 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 21 Apr 2021 1,500 199,654 - 0.6 900 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 31.07 per share. 21 Apr 2021 1,500 198,154 - 31.1 46,605 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Apr 2021 1,500 28,194 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 16 Apr 2021 1,500 199,654 - 0.6 900 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 28.03 per share. 16 Apr 2021 1,500 198,154 - 28.0 42,045 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 26.61 per share. 12 Apr 2021 10,771 66,558 - 26.6 286,616 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 26.78 per share. 12 Apr 2021 12,874 0 - 26.8 344,766 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 26.40 per share. 12 Apr 2021 10,539 12,874 - 26.4 278,230 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.53 per share. 12 Apr 2021 7,354 23,413 - 25.5 187,748 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 25.09 per share. 12 Apr 2021 35,791 30,767 - 25.1 897,996 Common Stock
Jason P. Rhodes Director Sale of securities on an exchange or to another person at price $ 26.07 per share. 12 Apr 2021 63,353 77,329 - 26.1 1,651,613 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 26.12 per share. 12 Apr 2021 4,900 199,254 - 26.1 127,988 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Apr 2021 6,000 29,694 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 26.78 per share. 12 Apr 2021 1,100 198,154 - 26.8 29,458 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 12 Apr 2021 6,000 204,154 - 0.6 3,600 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 30.68 per share. 05 Apr 2021 3,321 326,558 - 30.7 101,888 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2021 14,072 42,217 - - Stock Option (right to buy)
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 29.91 per share. 05 Apr 2021 10,751 329,879 - 29.9 321,562 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.16 per share. 05 Apr 2021 14,072 340,630 - 5.2 72,612 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2021 10,500 35,694 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 35.28 per share. 10 Mar 2021 5,950 198,154 - 35.3 209,916 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 34.57 per share. 10 Mar 2021 4,550 204,104 - 34.6 157,294 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 10 Mar 2021 10,500 208,654 - 0.6 6,300 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 33.75 per share. 05 Mar 2021 400 327,158 - 33.8 13,500 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 32.97 per share. 05 Mar 2021 775 327,558 - 33.0 25,552 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 31.87 per share. 05 Mar 2021 4,315 328,333 - 31.9 137,519 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 30.92 per share. 05 Mar 2021 2,500 332,648 - 30.9 77,300 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 05 Mar 2021 11,267 337,825 - 4.6 51,716 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 29.68 per share. 05 Mar 2021 2,677 335,148 - 29.7 79,453 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Mar 2021 11,267 89,959 - - Stock Option (right to buy)
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 35.58 per share. 05 Mar 2021 100 326,558 - 35.6 3,558 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 34.77 per share. 05 Mar 2021 500 326,658 - 34.8 17,385 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 41.38 per share. 03 Mar 2021 3,000 0 - 41.4 124,140 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Mar 2021 3,000 91,407 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 03 Mar 2021 3,000 3,000 - 4.6 13,770 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 38.12 per share. 01 Mar 2021 4,289 1,194,080 - 38.1 163,497 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 37.44 per share. 01 Mar 2021 4,321 1,198,369 - 37.4 161,778 Common Stock
Geoffrey McDonough Director, PRESIDENT AND CEO Sale of securities on an exchange or to another person at price $ 36.35 per share. 01 Mar 2021 1,390 1,202,690 - 36.4 50,527 Common Stock
Ronald H.W. Cooper Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2021 30,000 30,000 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 40.03 per share. 01 Mar 2021 1,000 200 - 40.0 40,030 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 2,500 94,407 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 40.71 per share. 01 Mar 2021 200 0 - 40.7 8,142 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 38.74 per share. 01 Mar 2021 200 1,200 - 38.7 7,748 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 37.81 per share. 01 Mar 2021 900 1,400 - 37.8 34,029 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 35.75 per share. 01 Mar 2021 200 2,300 - 35.8 7,150 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 01 Mar 2021 2,500 2,500 - 4.6 11,475 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 10 Feb 2021 10,400 208,554 - 0.6 6,240 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2021 10,400 46,194 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 35.58 per share. 10 Feb 2021 1,741 198,154 - 35.6 61,945 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 34.76 per share. 10 Feb 2021 6,030 199,895 - 34.8 209,603 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 33.59 per share. 10 Feb 2021 2,629 205,925 - 33.6 88,308 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 33.01 per share. 02 Feb 2021 7,500 330,325 - 33.0 247,575 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Feb 2021 11,267 101,226 - - Stock Option (right to buy)
Douglas Kerr CHIEF MEDICAL OFFICER Sale of securities on an exchange or to another person at price $ 34.08 per share. 02 Feb 2021 3,767 326,558 - 34.1 128,379 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 02 Feb 2021 11,267 337,825 - 4.6 51,716 Common Stock
Douglas Kerr CHIEF MEDICAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 73,500 73,500 - - Stock Option (right to buy)
Geoffrey McDonough Director, PRESIDENT AND CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 251,000 251,000 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 30,000 30,000 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 73,500 73,500 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 6,100 6,100 - - Stock Option (right to buy)
Matthew Norkunas CHIEF FINANCIAL OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 32,823 32,823 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 33.05 per share. 22 Jan 2021 2,500 0 - 33.1 82,625 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jan 2021 2,500 96,907 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2021 29,478 29,478 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 22 Jan 2021 2,500 2,500 - 4.6 11,475 Common Stock
Mark D. Angelino CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 33.18 per share. 15 Jan 2021 2,900 346,737 - 33.2 96,222 Common Stock
Mark D. Angelino CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jan 2021 7,500 110,960 - - Stock Option (right to buy)
Mark D. Angelino CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 34.96 per share. 15 Jan 2021 600 345,637 - 35.0 20,976 Common Stock
Mark D. Angelino CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 34.12 per share. 15 Jan 2021 500 346,237 - 34.1 17,060 Common Stock
Mark D. Angelino CHIEF OPERATING OFFICER Sale of securities on an exchange or to another person at price $ 32.29 per share. 15 Jan 2021 3,500 349,637 - 32.3 113,015 Common Stock
Mark D. Angelino CHIEF OPERATING OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 15 Jan 2021 7,500 353,137 - 4.6 34,425 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jan 2021 5,630 56,594 - - Stock Option (right to buy)
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 34.00 per share. 14 Jan 2021 2,790 198,154 - 34 94,860 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Sale of securities on an exchange or to another person at price $ 31.11 per share. 14 Jan 2021 2,840 200,944 - 31.1 88,352 Common Stock
Matthew Stanton CHIEF SCIENTIFIC OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. 14 Jan 2021 5,630 203,784 - 0.6 3,378 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. 14 Jan 2021 2,500 2,500 - 4.6 11,475 Common Stock
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jan 2021 2,500 99,407 - - Stock Option (right to buy)
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER Sale of securities on an exchange or to another person at price $ 33.09 per share. 14 Jan 2021 2,500 0 - 33.1 82,725 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters